Abstract
The production of megakaryocytes (MKs) and platelets is a finely controlled process that maintains circulating platelet numbers within a narrow range in normal individuals while providing sufficient reserve capacity for rapid production in emergencies such as bleeding. Forty years ago, it was recognized that a humoral regulator circulating in thrombocytopenic animals was able to stimulate platelet production in normal recipients (1). Termed thrombopoietin (TPO), the properties of this activity were defined over subsequent years but only in the early 1990s was the cDNA encoding TPO cloned (2–5). The availability of recombinant TPO allowed precise analysis of the properties of this cytokine in vitro and in vivo. These analyses, coupled with studies in mice lacking the genes for TPO or its receptor, c-Mpl, conclusively demonstrated that TPO is the major physiological regulator of steady-state platelet production (6,7). It is anticipated that the potent capacity of TPO to stimulate platelet production in vivo will allow improved clinical management of thrombocytopenia (8). Accordingly, TPO and related c-Mpl ligands are currently being evaluated as clinical reagents for the stimulation of platelets in thrombocytopenic patients, particularly following cytotoxic cancer treatment.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Kelemen, E., Cserhati, B., and Tanos, B. (1958) Demonstration and some properties of human thrombopoietin in thrombocytopenic serum. Acta Hematol. 20, 350–353.
Kuter, D. J., Beeler, D. L., and Rosenberg, R. D. (1994) The purification of megapoietin: a physiological regulator of megakaryocyte growth and platelet production. Proc. Natl. Acad. Sci. USA 91, 11,104–11,108.
Lok, S. and Foster, D. C. (1994) The structure, biology and potential therapeutic applications of recombinant thrombopoietin. Stem Cells 12, 586–598.
de Sauvage, F. J., Hass, P. E., Spencer, S. D., Malloy, B. E., Gurney, A. L., Spencer, S. A., et al. (1994) Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand. Nature 369, 533–538.
Bartley, T. D., Bogenberger, J., Hunt, P., Li, Y. S., Lu, H. S., Martin, F., et al. (1994) Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor Mpl. Cell 77, 1117–1124.
Alexander, W. S. (1999) Thrombopoietin and the c-Mpl receptor: insights from gene targeting. Int. J. Biochem. Cell Biol. 31, 1027–1035.
Alexander, W. S. (1999) Thrombopoietin. Growth Factors 17, 13–24.
Kuter, D. J. (2000) Future directions with platelet growth factors. Semin. Hematol. 37, 41–49.
Foster, D. C., Sprecher, C. A., Grant, F. J., Kramer, J. M., Kuijper, J. L., Holly, R. D., et al. (1994) Human thrombopoietin: gene structure, cDNA sequence, expression, and chromosomal localization. Proc. Natl. Acad. Sci. USA 91, 13,023–13,027.
Chang, M. S., Hsu, R. Y., McNinch, J., Copeland, N. G., and Jenkins, N. A. (1995a) The gene for murine megakaryocyte growth and development factor (thrombopoietin, Thpo) is located on mouse chromosome 16. Genomics 26, 636–637.
Sungaran, R., Markovic, B., and Chong, B. H. (1997) Localization and regulation of thrombopoietin mRNA expression in human kidney, liver, bone marrow, and spleen using in situ hybridization. Blood 89, 101–107.
Nagahisa, H., Nagata, Y., Ohnuki, T., Osada, M., Nagasawa, T., Abe, T., and Todokoro, K. (1996) Bone marrow stromal cells produce thrombopoietin and stimulate megakaryocyte growth and maturation but suppress proplatelet formation. Blood 87, 1309–1316.
Hunt, P. (1995) The physiologic role and therapeutic potential of the Mpl-ligand in thrombopoiesis. Stem Cells 13, 579–587.
Hunt, P., Li, Y. S., Nichol, J. L., Hokom, M. M., Bogenberger, J. M., Swift, S. E., et al. (1995) Purification and biologic characterization of plasma-derived megakaryocyte growth and development factor. Blood 86, 540–547.
Kato, T., Ogami, K., Shimada, Y., Iwamatsu, A., Sohma, Y., Akahori, H., et al. (1995) Purification and characterization of thrombopoietin. J. Biochem. 118, 229–236.
Linden, H. M. and Kaushansky, K. (2000) The glycan domain of thrombopoietin enhances its secretion. Biochemistry 39, 3044–3051.
Muto, T., Feese, M. D., Shimada, Y., Kudou, Y., Okamoto, T., Ozawa, T., et al. (2000) Functional analysis of the C-terminal region of recombinant human thrombopoietin. C-terminal region of thrombopoietin is a “shuttle” peptide to help secretion. J. Biol. Chem. 275, 12,090–12,094.
Stoffel, R., Wiestner, A., and Skoda, R. C. (1996) Thrombopoietin in thrombocytopenic mice: evidence against regulation at the mRNA level and for a direct regulatory role of platelets. Blood 87, 567–573.
Stefanich, E., Senn, T., Widmer, R., Fratino, C., Keller, G. A., and Fielder, P. J. (1997) Metabolism of thrombopoietin (TPO) in vivo: determination of the binding dynamics for TPO in mice. Blood 89, 4063–4070.
Broudy, V. C., Lin, N. L., Sabath, D. F., Papayannopoulou, T., and Kaushansky, K. (1997) Human platelets display high-affinity receptors for thrombopoietin. Blood 89, 1896–1904.
Fielder, P. J., Hass, P., Nagel, M., Stefanich, E., Widmer, R., Bennett, G. L., et al. (1997) Human platelets as a model for the binding and degradation of thrombopoietin. Blood 89, 2782–2788.
Souyri, M. (1998) Mpl: from an acute myeloproliferative virus to the isolation of the long sought thrombopoietin. Semin. Hematol. 35, 222–231.
Palacios, R. and Steinmetz, M. (1985) IL-3-dependent mouse clones that express B-220 surface antigen, contain Ig genes in germ-line configuration, and generate B lymphocytes in vivo. Cell 41, 727–734.
Metcalf, D., Willson, T. A., Hilton, D. J., Di Rago, L., and Mifsud, S. (1995) Production of hematopoietic regulatory factors in cultures of adult and fetal mouse organs: measurement by specific bioassays. Leukemia 9, 1556–1564.
Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989) Molecular Cloning, A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
Alexander, W. S. and Dunn, A. R. (1995) Structure and transcription of the genomic locus encoding murine c-Mpl, a receptor for thrombopoietin. Oncogene 10, 795–803.
Alexander, W. S., Maurer, A. B., Novak, U., and Harrison-Smith, M. (1996) Tyrosine-599 of the c-Mpl receptor is required for Shc phosphorylation and the induction of cellular differentiation. Embo. J. 15, 6531–6540.
Kunkel, T. A. (1985) Rapid and efficient site-specific mutagenesis without phenotypic selection. Proc. Natl. Acad. Sci. USA 82, 488–492.
Miller, A. D. and Rosman, G. J. (1989) Improved retroviral vectors for gene transfer and expression. Biotechniques 7, 980–982, 984–986, 989–990.
Metcalf, D. (1984) Hemopoietic Colony-stimulating Factors. Elsevier, Amsterdam.
Metcalf, D., Willson, T., Rossner, M. and Lock, P. (1994) Receptor insertion into factor-dependent murine cell lines to develop specific bioassays for murine G-CSF and M-CSF and human GM-CSF. Growth Factors 11, 145–152.
Sugar, I. P. and Neumann, E. (1984) Stochastic model for electric field-induced membrane pores. Electroporation. Biophys. Chem. 19, 211–225.
Moritz, R. L., Ward, L. D., Tu, G. F., Fabri, L. J., Ji, H., Yasukawa, K., et al. (1999) The N-terminus of gp130 is critical for the formation of the high-affinity interleukin-6 receptor complex. Growth Factors 16, 265–278.
Mizushima, S. and Nagata, S. (1990) pEF-BOS, a powerful mammalian expression vector. Nucleic Acids Res. 18, 5322.
Nichol, J. L. (1998) Thrombopoietin levels after chemotherapy and in naturally occurring human diseases. Curr. Opin. Hematol. 5, 203–208.
Verbeek, W., Faulhaber, M., Griesinger, F., and Brittinger, G. (2000) Measurement of thrombopoietic levels: clinical and biological relationships. Curr. Opin. Hematol. 7, 143–149.
Park, H. and Hong, H. J. (1997) Development of an in vitro bioassay system for human thrombopoietin by constructing a recombinant murine cell line expressing human thrombopoietin receptor. Mol. Cells 7, 699–704.
Alexander, W. S., Metcalf, D., and Dunn, A. R. (1995) Point mutations within a dimer interface homology domain of c-Mpl induce constitutive receptor activity and tumorigenicity. Embo. J. 14, 5569–5578.
Page, L. A., Thorpe, R., and Mire-Sluis, A. R. (1996) A sensitive human cell line based bioassay for megakaryocyte growth and development factor or thrombopoietin. Cytokine 8, 66–69.
Komatsu, N., Kunitama, M., Yamada, M., Hagiwara, T., Kato, T., Miyazaki, H., et al. (1996) Establishment and characterization of the thrombopoietin-dependent megakaryocytic cell line, UT-7/TPO. Blood 87, 4552–4560.
Matsumura, I., Nakajima, K., Wakao, H., Hattori, S., Hashimoto, K., Sugahara, H., et al. (1998) Involvement of prolonged ras activation in thrombopoietin-induced megakaryocytic differentiation of a human factor-dependent hematopoietic cell line. Mol. Cell Biol. 18, 4282–4290.
Lok, S., Kaushansky, K., Holly, R. D., Kuijper, J. L., Lofton-Day, C. E., Oort, P. J., et al. (1994) Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo. Nature 369, 565–568.
Tahara, T., Usuki, K., Sato, H., Ohashi, H., Morita, H., Tsumura, H., et al. (1996) A sensitive sandwich ELISA for measuring thrombopoietin in human serum: serum thrombopoietin levels in healthy volunteers and in patients with haemopoietic disorders. Br. J. Haematol. 93, 783–788.
Folman, C. C., mnvon dem Borne, A. E., Rensink, I. H., Gerritsen, W., van der Schoot, C. E., de Haas, M., et al. (1997) Sensitive measurement of thrombopoietin by a monoclonal antibody based sandwich enzyme-linked immunosorbent assay. Thromb. Haemost. 78, 1262–1267.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Humana Press Inc.
About this protocol
Cite this protocol
Alexander, W.S., Hyland, C. (2004). Thrombopoietin Bioassay. In: Gibbins, J.M., Mahaut-Smith, M.P. (eds) Platelets and Megakaryocytes. Methods In Molecular Biology™, vol 272. Humana Press. https://doi.org/10.1385/1-59259-782-3:347
Download citation
DOI: https://doi.org/10.1385/1-59259-782-3:347
Publisher Name: Humana Press
Print ISBN: 978-1-58829-101-1
Online ISBN: 978-1-59259-782-6
eBook Packages: Springer Protocols